QS Investors’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

QS Investors’s Portfolio SGNT Stock Details SGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-40,300	Closed	-$604K	–	2031
2016 Q2	$604K	Hold	40,300	–	–	0.01%	869
2016 Q1	$490K	Hold	40,300	–	–	﹤0.01%	900
2015 Q4	$641K	Hold	40,300	–	–	0.01%	867
2015 Q3	$618K	Hold	40,300	–	–	0.01%	851
2015 Q2	$980K	Sell	40,300 -3,800	-9%	-$91K	0.01%	763
2015 Q1	$1.03M	Sell	44,100 -21,600	-33%	-$572K	0.01%	745
2014 Q4	$1.65M	Buy	+65,700	New	+$1.93M	0.02%	628

QS Investors's SGNT Position: Q3 2016 in Review

QS Investors sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 40,300 shares — an estimated $604K sold.

QS Investors first reported a position in SGNT in Q4 2014 and held it in 7 quarters. The position peaked at $1.65M in Q4 2014. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

QS Investors reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
QS Investors sold 40,300 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $604K.
QS Investors first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q4 2014 and held it in 7 quarters.
QS Investors's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $1.65M in Q4 2014.
0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on QS Investors's 13F filing for Q3 2016, filed 14 Nov 2016.